Dhanvantri Jeev.

Market Cap: Micro Cap
Industry: Healthcare Services
ISIN: INE239F01015
NSEID:
BSEID: 531043
View on BSE

INR

23.28

-1.22 (-4.98%)

BSENSE

Mar 05

BSE+NSE Vol: 35

{
  "main_header": {
    "sid": 185785,
    "name": "Dhanvantri Jeev.",
    "stock_name": "Dhanvantri Jeev.",
    "full_name": "Dhanvantri Jeevan Rekha Ltd",
    "name_url": "stocks-analysis/dhanvantri-jeev",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "23.28",
    "chg": -1.22,
    "chgp": "-4.98%",
    "dir": -1,
    "prev_price": "24.50",
    "mcapval": "10.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531043,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE239F01015",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "35 ",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dhanvantri-jeev-185785-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-technical-signals-3846422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_mojoScore_3846422.png",
        "date": "2026-02-19 08:11:24",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Feb 2026. Despite some positive quarterly financial results, the company’s overall quality, valuation, financial trend, and technical indicators present a complex picture that has led to a cautious stance among investors."
      },
      {
        "title": "Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-dhanvantri-jeevan-rekha-ltd-latest-results-good-or-bad-3838180",
        "imagepath": "",
        "date": "2026-02-13 19:54:35",
        "description": "Dhanvantri Jeevan Rekha Ltd's latest financial results for Q3 FY26 indicate a notable operational recovery, with net sales reaching ₹7.27 crores, reflecting a year-on-year growth of 27.54%. This marks a significant improvement compared to the previous year, where the growth was only 10.68%. The company's net profit also showed a positive trend, amounting to ₹0.17 crores, which is a 13.33% increase from the same quarter last year, contrasting with a substantial loss in the prior year.\n\nThe operating margin for the quarter stood at 3.99%, the highest in eight quarters, suggesting an improvement in operational efficiency. However, the company continues to face challenges in capital efficiency, as evidenced by an average return on equity of 2.25% and a negative return on capital employed of -4.36%. These metrics highlight ongoing structural issues that the company must address to enhance shareholder value.\n\nDes..."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Q3 FY26: Operational Recovery Masks Underlying Fragility",
        "link": "https://www.marketsmojo.com/news/result-analysis/dhanvantri-jeevan-rekha-q3-fy26-operational-recovery-masks-underlying-fragility-3836127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_quaterlyResult_3836127.png",
        "date": "2026-02-12 20:16:47",
        "description": "Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a sharp operational turnaround in Q3 FY26, posting net profit of ₹0.17 crores—a dramatic recovery from the ₹0.14 crore loss recorded in Q2 FY26. However, with a market capitalisation of just ₹10.00 crores and elevated valuation metrics, the company's financial fragility remains a significant concern for investors despite the sequential improvement."
      },
      {
        "title": "Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-dhanvantri-jeevan-rekha-ltd-latest-results-good-or-bad-3835703",
        "imagepath": "",
        "date": "2026-02-12 19:45:41",
        "description": "Dhanvantri Jeevan Rekha Ltd's latest financial results for Q2 FY26 present a complex picture characterized by contrasting operational trends. The company reported a net profit of -₹0.14 crores, a notable shift from a profit of ₹0.06 crores in the previous quarter, indicating a significant decline in profitability. This marks a concerning reversal from the modest profits observed in the prior two quarters.\n\nOn the revenue front, Dhanvantri Jeevan Rekha achieved a net sales figure of ₹5.84 crores, reflecting a year-on-year growth of 7.75% and a sequential increase of 5.99%. This revenue performance represents the highest quarterly sales in seven quarters, indicating a positive trend in top-line growth. However, this growth did not translate into improved profitability, as the operating margin fell to -1.20%, the lowest level in seven quarters, highlighting challenges in managing operational costs effectively...."
      },
      {
        "title": "When is the next results date for Dhanvantri Jeevan Rekha Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-dhanvantri-jeevan-rekha-ltd-3825170",
        "imagepath": "",
        "date": "2026-02-06 23:18:05",
        "description": "The next results date for Dhanvantri Jeevan Rekha Ltd is scheduled for 12 February 2026...."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-sell-amid-mixed-technicals-and-weak-fundamentals-3821826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_mojoScore_3821826.png",
        "date": "2026-02-05 08:12:42",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 4 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, underscoring a cautious stance for investors."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-fundamentals-3815715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DhanvantriJeeva_mojoScore_3815715.png",
        "date": "2026-02-02 08:19:27",
        "description": "Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 30 Jan 2026. Despite some mild technical improvements, the company’s weak financial trends and poor valuation metrics have weighed heavily on its overall assessment, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Why is Dhanvantri Jeevan Rekha Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dhanvantri-jeevan-rekha-ltd-fallingrising-3790701",
        "imagepath": "",
        "date": "2026-01-14 00:44:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s recent price action reveals a clear downward trajectory over the past week and month, with losses of 4.97% and 4.86% respectively. These declines are more pronounced than the Sensex benchmark, which fell by 1.69% over the week and 1.92% over the month. Year-to-date, the stock has dropped 6.87%, significantly underperforming the Sensex’s 1.87% decline. This divergence suggests that the stock is facing pressures beyond general market movements, possibly linked to company-specific factors or sector dynamics.</p>\n<p>On 13-Jan, the stock opened with a gap down of 2.16%, indicating immediate selling pressure at the start of trading. Throughout the day, it touched an intraday low of ₹23.32, marking the full extent of the 4.97%..."
      },
      {
        "title": "Dhanvantri Jeevan Rekha Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dhanvantri-jeevan-rekha-ltd-is-rated-sell-3771598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DhanvantriJeeva_mojoScore_3771598.png",
        "date": "2025-12-26 21:51:26",
        "description": "Dhanvantri Jeevan Rekha Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 481,
    "sid": "185785",
    "stock_news_url": "https://www.marketsmojo.com/news/dhanvantri-jeevan-rekha-185785"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Feb-2026",
      "details": "PFA the newsapaper clipping of the result quater ending dec 2025",
      "source": "BSE"
    },
    {
      "caption": "Result Forquater Dec 2025",
      "datetime": "12-Feb-2026",
      "details": "Please find the result for the dec quarter 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Quartely Results For The Quater Ending Dec 2025",
      "datetime": "12-Feb-2026",
      "details": "Outcome of the noard meeting heldon 12-02-2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dhanvantri Jeevan Rekha Ltd has declared <strong>4%</strong> dividend, ex-date: 15 Sep 11",
          "dt": "2011-09-15",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Financial and Technical Signals

2026-02-19 08:11:24

Dhanvantri Jeevan Rekha Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Feb 2026. Despite some positive quarterly financial results, the company’s overall quality, valuation, financial trend, and technical indicators present a complex picture that has led to a cautious stance among investors.

Read full news article

Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?

2026-02-13 19:54:35

Dhanvantri Jeevan Rekha Ltd's latest financial results for Q3 FY26 indicate a notable operational recovery, with net sales reaching ₹7.27 crores, reflecting a year-on-year growth of 27.54%. This marks a significant improvement compared to the previous year, where the growth was only 10.68%. The company's net profit also showed a positive trend, amounting to ₹0.17 crores, which is a 13.33% increase from the same quarter last year, contrasting with a substantial loss in the prior year. The operating margin for the quarter stood at 3.99%, the highest in eight quarters, suggesting an improvement in operational efficiency. However, the company continues to face challenges in capital efficiency, as evidenced by an average return on equity of 2.25% and a negative return on capital employed of -4.36%. These metrics highlight ongoing structural issues that the company must address to enhance shareholder value. Des...

Read full news article

Dhanvantri Jeevan Rekha Q3 FY26: Operational Recovery Masks Underlying Fragility

2026-02-12 20:16:47

Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a sharp operational turnaround in Q3 FY26, posting net profit of ₹0.17 crores—a dramatic recovery from the ₹0.14 crore loss recorded in Q2 FY26. However, with a market capitalisation of just ₹10.00 crores and elevated valuation metrics, the company's financial fragility remains a significant concern for investors despite the sequential improvement.

Read full news article

Are Dhanvantri Jeevan Rekha Ltd latest results good or bad?

2026-02-12 19:45:41

Dhanvantri Jeevan Rekha Ltd's latest financial results for Q2 FY26 present a complex picture characterized by contrasting operational trends. The company reported a net profit of -₹0.14 crores, a notable shift from a profit of ₹0.06 crores in the previous quarter, indicating a significant decline in profitability. This marks a concerning reversal from the modest profits observed in the prior two quarters. On the revenue front, Dhanvantri Jeevan Rekha achieved a net sales figure of ₹5.84 crores, reflecting a year-on-year growth of 7.75% and a sequential increase of 5.99%. This revenue performance represents the highest quarterly sales in seven quarters, indicating a positive trend in top-line growth. However, this growth did not translate into improved profitability, as the operating margin fell to -1.20%, the lowest level in seven quarters, highlighting challenges in managing operational costs effectively....

Read full news article

When is the next results date for Dhanvantri Jeevan Rekha Ltd?

2026-02-06 23:18:05

The next results date for Dhanvantri Jeevan Rekha Ltd is scheduled for 12 February 2026....

Read full news article

Dhanvantri Jeevan Rekha Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals

2026-02-05 08:12:42

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 4 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, underscoring a cautious stance for investors.

Read full news article

Dhanvantri Jeevan Rekha Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals

2026-02-02 08:19:27

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 30 Jan 2026. Despite some mild technical improvements, the company’s weak financial trends and poor valuation metrics have weighed heavily on its overall assessment, prompting a reassessment of its investment appeal.

Read full news article

Why is Dhanvantri Jeevan Rekha Ltd falling/rising?

2026-01-14 00:44:11

Short-Term Price Movement and Market Context

The stock’s recent price action reveals a clear downward trajectory over the past week and month, with losses of 4.97% and 4.86% respectively. These declines are more pronounced than the Sensex benchmark, which fell by 1.69% over the week and 1.92% over the month. Year-to-date, the stock has dropped 6.87%, significantly underperforming the Sensex’s 1.87% decline. This divergence suggests that the stock is facing pressures beyond general market movements, possibly linked to company-specific factors or sector dynamics.

On 13-Jan, the stock opened with a gap down of 2.16%, indicating immediate selling pressure at the start of trading. Throughout the day, it touched an intraday low of ₹23.32, marking the full extent of the 4.97%...

Read full news article

Dhanvantri Jeevan Rekha Ltd is Rated Sell

2025-12-26 21:51:26

Dhanvantri Jeevan Rekha Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.